Journal
WORLD JOURNAL OF CLINICAL CASES
Volume 10, Issue 15, Pages 4878-4885Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.12998/wjcc.v10.i15.4878
Keywords
Familial gastrointestinal stromal tumor; Germline KIT mutation; Cutaneous hyperpigmentation; Imatinib therapy; Case report
Categories
Funding
- Shanghai Municipal Key 306 Clinical Specialty [shslczdzk01302]
Ask authors/readers for more resources
In this study, two patients (father and daughter) in a Chinese family with germline KIT mutation were reported for the first time. Their pathology, genetics and clinical manifestations were described. The patients showed multiple tumors in the small intestine and pigmented spots on the skin. Imatinib therapy showed long-lasting disease stability and hypopigmentation of the skin could also be observed. However, the daughter of the female patient did not have the germline KIT mutation.
BACKGROUND Familial gastrointestinal stromal tumors (GISTs) is a rare autosomal dominant disorder characterized by an array of clinical manifestations. Only 35 kindreds with germline KIT mutations and six with germline PDGFRA mutations have been reported so far. It is often characterized by a series of manifestations, such as multiple lesions and hyperpigmentation. However, the effect of imatinib treatment in these patients is still uncertain. CASE SUMMARY Here, we report two patients (father and daughter) in a Chinese family (for the first time) with germline KIT mutation, and described their pathology, genetics and clinical manifestations. A 25-year-old Chinese woman went to hospital because of abdominal pain, and computed tomography showed multiple tumors in the small intestine. Small pigmented spots appeared on the skin within a few months after birth. Her father also had multiple pigmented spots and a history of multifocal GISTs. Multiple GISTs associated with diffuse interstitial Cajal cells (ICCs) hyperplasia were positive for CD117 and DOG-1. Gene sequencing revealed a germline mutation at codon 560 of exon 11 (p.V560G) of KIT gene in these two patients. Imatinib therapy showed the long-lasting disease stability after resection. Remarkably, the hypopigmentation of the skin could also be observed. Luckily germline KIT mutation has not been identified yet in the 3-year-old daughter of the female patient. CONCLUSION Diagnosis of familial GISTs depends on combination of diffuse ICCs hyperplasia, germline KIT/PDGFRA mutation, hyperpigmentation and family history.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available